This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters None
0 out of 7 registries used, show all original rules.
0
Check minimum number of events None
0
Remove individuals based on genotype QC
2119
MYELOPROF
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2, additional
No data for upset plot.
No data for upset table.
Similar endpoints
↥List of similar endpoints to
Myeloproliferative diseases
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2119 | 1092 | 1027 |
| Unadjusted prevalence (%) | 0.56 | 0.52 | 0.62 |
| Mean age at first event (years) | 61.21 | 60.19 | 62.30 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: MYELOPROF – Myeloproliferative diseases
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Myeloproliferative diseases
↥Endpoint not on priority list, no data to show.